Kevin Sayer
Executive Chairman
Board member since 2007
Mr. Sayer’s extensive executive experience operating companies in the diabetes and medical technology industry provides Dexcom with both operational and strategic industry-specific expertise to our Board.
Career Highlights:
- Executive Chair of the Board since 2026, and Chairman of the Board since 2018
- CEO of Dexcom from 2015 to 2025, and a Dexcom executive since 2011
- Former CFO of Biosensors International Group, Ltd.
- Former CFO of Specialty Laboratories, Inc.
- Former CFO of MiniMed, Inc., and former VP and General Manager of Medtronic MiniMed after the acquisition of MiniMed by Medtronic
Key Experience and Qualifications:
- Executive oversight of strategy and operations
- Significant biosensing and diabetes industry experience
Education:
- Bachelor’s and Master’s degrees in Accounting and Information Systems from Brigham Young University
- Certified Public Accountant (inactive)